Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial

Xiaofeng Liang(Chinese Center For Disease Control and Prevention), Huaqing Wang(Chinese Center For Disease Control and Prevention), Junzhi Wang(National Institutes for Food and Drug Control), Han-Hua Fang(National Institutes for Food and Drug Control), Jiang Wu(Centers for Disease Control and Prevention), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Rongcheng Li(Guangxi Center for Disease Prevention and Control), Shengli Xia(Henan Provincial Center for Disease Control and Prevention), Yuliang Zhao(Hebei Provincial Center for Disease Control and Prevention), Fangjun Li(Hunan Provincial Center for Disease Control and Prevention), Shao-Hong Yan(Inner Mongolia Comprehensive Disease Prevention and Control Center), Weidong Yin(Sinovac Biotech), Kang An, Duo-Jia Feng(National Center for Genetic Engineering and Biotechnology), Xuan-Lin Cui, QI Feng-chun(Changchun Institute of Biological Products), Chang-Jun Ju, Yuhui Zhang, Zhijun Guo, Ping‐Yu Chen(Lanzhou Institute of Husbandry and Pharmaceutical Sciences), Ze Chen, Kunming Yan, Yu Wang(Chinese Center For Disease Control and Prevention)
The Lancet
December 16, 2009
Cited by 254

Abstract


Related Papers

No related papers found

Powered by citation graph analysis